NCT01146171 2012-02-07
Japanese Phase 1 Study of BMS-844203 (CT322)
Bristol-Myers Squibb
Phase 1 Withdrawn
Clinical Trials
3 trialsNCT00768911 2010-10-27
CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
Adnexus, A Bristol-Myers Squibb R&D Company
Phase 1 Unknown
NCT00374179 2009-02-24
CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma
Adnexus, A Bristol-Myers Squibb R&D Company
Phase 1 Completed